André Weinstock

Company: Alport Syndrome Foundation

Job title: Research Director

Seminars:

12:00 PM Panel Discussion: Defining Surrogate Endpoints for Rare & Genetic Kidney Disease 12:00 pm

Current regulatory perspectives on surrogate endpoints such as proteinuria in rare kidney diseases Industry perspectives on balancing the need for a 'registrable' surrogate endpoint with the goal of achieving a 'clinically compelling' outcome for patients Patient views on the use of surrogate endpoints in clinical trialsRead more

day: Conference Day 1

11:00 AM Pioneering Predictive Biomarkers & Surrogate Endpoints in Rare & Genetic Kidney Disease for Streamlined Translational Development 11:00 am

Join this workshop to gain critical knowledge and practical strategies for leveraging predictive biomarkers and surrogate endpoints to significantly streamline the translational development pathway for therapies in rare and genetic kidney diseases, ultimately benefiting patients by accelerating the availability of new treatments. Defining appropriate early and reliable biomarkers to predict disease progression and response to…Read more

day: Pre-Conference Workshop Day